The present invention relates generally to the field of respiratory therapy. More particularly, the invention relates to positive airway pressure devices (PAP devices), respirators, ventilators, CPAP or VPAP devices and conduits that form a component of such devices, the conduits being used for conveying breathing gas from the device to a patient interface.
Respiratory devices typically include a flexible conduit to convey a breathing gas such as air to a patient. Generally, the conduit should be strong enough to prevent crushing or kinking, as such could cause occlusions in the conduit thereby restricting or blocking the delivery of breathing gas.
One known conduit structure includes a hard plastic or metal spiral reinforcement around the inside or outside of a thin-walled flexible plastic tube. This helical or spiral structure supports the tube and prevents occlusions. Preferably, the spiral is wound around the outside of the plastic tube so that the conduit maintains a smooth bore, such as in Smooth-Bor® tubing.
Humidified breathing gas may be delivered to a patient as part of their respiratory therapy. In this case, it is advantageous to minimise head transfer out of the conduit in order to avoid condensation of the humidified gas as it flows through the conduit. The condensation problem is particularly pronounced in cold environments.
Plastics and metals are not efficient thermal insulators. Therefore, in order to prevent condensation, additional structure may be added to the conduit. For example, an insulating sleeve may be used to cover the conduit and provide insulation. Another proposed solution involves using a heated wire to heat the conduit (Thermo-Smart® by Fisher & Paykel Healthcare). Actively heating the tube may result in the air temperature rising as it travels along the tube which in turn will result in the air drying out. Smooth-Bor™ also produces a dual-walled conduit that provides added insulation.
Present conduits can also be heavy causing an uncomfortable resistance to patient head movements. Additional items, such as an insulating sleeve, added to the conduit may cause the overall weight to increase. Additional items may also increase the friction of the conduit against surrounding items, such as bed linen.
A first aspect of the invention is to provide a conduit suitable to deliver air from a positive airway pressure device (PAP device), blower, flow generator or ventilator to a patient interface to provide respiratory therapy. In one form the conduit is at least partly constructed from a textile. In one form a wall of the conduit is at least partly constructed from a textile.
In one form, the wall is made from a non-porous, woven textile.
In one form, the textile is woven and porous but is treated such that it is substantially non-porous.
In one form, the textile is a woven textile, manufactured by a circular weaving manufacturing process. Advantageously, the resultant textile is tubular.
In one form, the conduit includes a reinforcing structure and a wall structure, and at least a portion of either the reinforcing structure or the wall structure includes a textile.
A second aspect of the invention is a method for manufacturing a wall of a conduit for conveying air from a respiratory device to a patient interface, the method comprising weaving a textile wall by a circular weaving technique.
Another aspect of the invention relates to an air delivery conduit for conveying breathable gas from a positive airway pressure device to a patient interface. The air delivery conduit includes a tubular wall structure constructed from a textile material and a reinforcing structure provided to the wall structure. The reinforcing structure is structured to prevent kinking or collapsing of the wall structure.
Another aspect of the invention relates to a method for manufacturing an air delivery conduit for conveying breathable gas from a positive airway pressure device to a patient interface. The method includes providing a warp having a plurality of lengthwise textile warp threads arranged in a circle, providing a weft having a textile weft thread, and weaving the weft thread through the plurality of warp threads in a circular weaving technique to produce a tubular wall structure.
Advantageously, textiles (including woven and non-woven textiles) usually provide better insulating properties than plastics and are often lighter in weight. A non-porous textile advantageously prevents breathing gas escaping from the conduit (and the resultant pressure losses).
Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.
The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:
As schematically shown in
For example,
In one form, the conduit includes a reinforcing structure and a wall structure, and at least a portion of either the reinforcing structure or the wall structure includes a textile. For example,
In the illustrated embodiment, the reinforcing structure 230 is a spiral structure attached to the textile wall 220 so that the resulting conduit is strong enough to prevent kinking or collapsing. A plastic reinforcing structure 230 that has a spiral/helical shape or a webbing could be used.
In an embodiment, the textile is a woven textile, manufactured by a circular weaving manufacturing process. The resultant textile is tubular. In circularly weaved conduits, the warp is circular and there are continuously circulating shuttles running around the periphery.
For example,
The textile itself could be made in a way that provides the strength to prevent kinking or obstruction. For example, the weft 360 could be made from a yarn that is semi-rigid, such as a nylon or metal, and the warp 350 would be made from another material that is flexible. This arrangement would result in a tubular structure that is flexible axially but not radially meaning that the tube would be flexible along its length but would prevent kinks and occlusions.
In one embodiment, the wall of the textile conduit may be made from a non-porous, woven textile while in another embodiment the wall may be made from a substantially porous, woven textile and is treated such that it is substantially non-porous. A non-porous textile prevents breathing gas escaping from the conduit and the resultant pressure losses which could encroach upon the effectiveness of the respiratory therapy.
Gas or air permeability depends on the yarn size and the tightness of the weave. The surface can be treated with a resin to close the pores, or a thin film such as polyethylene may be applied over the surface. In an embodiment, a membrane such as Winstopper® by W. L. Gore & Associates, Inc. may be used. This membrane is permeable to moisture but not gas. The membrane would be applied to the inside of the conduit. If any condensation is formed in the conduit, it will pass through the membrane to the outside of the tube.
A textile conduit may be better insulated than conventional plastic conduits. To provide further insulation to the tube, additional layers of textiles (such as Thinsulate®) may be used.
In one embodiment, insulating material could be provided between each or some of the spiral or other reinforcements and a fabric or other membrane could cover the reinforcements and insulating material. The insulating material could comprise an appropriate closed cell structure, such as a resilient foam.
A textile conduit may be lighter in weight than conventional plastic conduits.
A method for manufacturing a wall of a conduit for conveying air from a respiratory device to a patient interface is also provided. In an embodiment, the method comprises
Some of the advantages of using textiles (including woven and non-woven textiles) for a conduit are that they:
While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, barriatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.
Number | Date | Country | Kind |
---|---|---|---|
2006901506 | Mar 2006 | AU | national |
This application is a continuation application of U.S. application Ser. No. 15/425,891 filed Feb. 6, 2017, now U.S. Pat. No. 10,792,452 which is a divisional application of U.S. application Ser. No. 12/225,417, filed Jan. 29, 2009, now U.S. Pat. No. 9,566,408, which was the U.S. National Phase of International Application No. PCT/AU2007/000358, filed Mar. 22, 2007, which designated the U.S. and claimed the benefit of Australian Provisional Application No. AU 2006901506, filed Mar. 24, 2006, each of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2396059 | Roberts | Mar 1946 | A |
2813573 | Roberts | Nov 1957 | A |
2897840 | Roberts | Aug 1959 | A |
3037798 | Cooper | Jun 1962 | A |
3163707 | Darling | Dec 1964 | A |
3205913 | Sperry | Sep 1965 | A |
3312250 | Sirignano | Apr 1967 | A |
3709262 | Braunschweller | Jan 1973 | A |
3812885 | Sajben | May 1974 | A |
3857415 | Morin | Dec 1974 | A |
4259991 | Kutnyak | Apr 1981 | A |
4276908 | Home | Jul 1981 | A |
4308895 | Greco | Jan 1982 | A |
4357962 | Shaw | Nov 1982 | A |
4415389 | Medford | Nov 1983 | A |
4437462 | Piljay et al. | Mar 1984 | A |
4478661 | Lewis | Oct 1984 | A |
4553568 | Piccoli | Jan 1985 | A |
4714096 | Guay | Dec 1987 | A |
4842023 | Whitworth | Jun 1989 | A |
4848366 | Aita et al. | Jul 1989 | A |
5418051 | Caldwell | May 1995 | A |
5548842 | Wiseman | Aug 1996 | A |
5735266 | Smith | Apr 1998 | A |
5800402 | Bierman | Sep 1998 | A |
5843542 | Brushafer et al. | Dec 1998 | A |
6199676 | Targiroff | Mar 2001 | B1 |
6508276 | Radinger | Jan 2003 | B2 |
6769431 | Smith et al. | Aug 2004 | B2 |
6779522 | Smith | Aug 2004 | B2 |
7469719 | Gray | Dec 2008 | B2 |
7481221 | Kullik et al. | Jan 2009 | B2 |
7926517 | Horimoto | Apr 2011 | B2 |
8435216 | Spinoza | May 2013 | B2 |
9566408 | Henry | Feb 2017 | B2 |
9656038 | Rummery | May 2017 | B2 |
10729869 | Rummery | Aug 2020 | B2 |
20010039972 | Badders | Nov 2001 | A1 |
20010054422 | Smith | Dec 2001 | A1 |
20020005197 | Devries et al. | Jan 2002 | A1 |
20030070680 | Smith et al. | Apr 2003 | A1 |
20040045549 | Smith | Mar 2004 | A1 |
20040079371 | Gray | Apr 2004 | A1 |
20040194781 | Fukunaga | Oct 2004 | A1 |
20040211422 | Arcilla et al. | Oct 2004 | A1 |
20040226813 | Wang | Nov 2004 | A1 |
20060165829 | Smith | Jul 2006 | A1 |
20070207186 | Scanlon | Sep 2007 | A1 |
20080173305 | Frater | Jul 2008 | A1 |
20080178957 | Thomas | Jul 2008 | A1 |
20080202512 | Kressierer et al. | Aug 2008 | A1 |
20080202620 | Van Hooren | Aug 2008 | A1 |
20080228028 | Carlson et al. | Sep 2008 | A1 |
20100018534 | Veliss et al. | Jan 2010 | A1 |
20100224195 | Henry | Sep 2010 | A1 |
20100255270 | Steubiger | Oct 2010 | A1 |
20110303318 | Nicolas | Dec 2011 | A1 |
20130180615 | Ragner | Jul 2013 | A1 |
20140102456 | Ovizinsky | Apr 2014 | A1 |
20160296720 | Henry | Oct 2016 | A1 |
20170143929 | Henry | May 2017 | A1 |
20180043120 | Hunley | Feb 2018 | A1 |
20190015192 | Nakazawa | Jan 2019 | A1 |
Number | Date | Country |
---|---|---|
8014121 | Apr 1990 | BR |
1106101 | Aug 1981 | CA |
393686 | Oct 1990 | EP |
430117 | Jun 1991 | EP |
656352 | Aug 1951 | GB |
05-254164 | Sep 1994 | JP |
9047159 | Feb 1997 | JP |
2001-336678 | Dec 2001 | JP |
2003-275228 | Sep 2003 | JP |
2009-072596 | Apr 2009 | JP |
2014-514035 | Jun 2014 | JP |
2014-167343 | Sep 2014 | JP |
2018-527156 | Sep 2018 | JP |
1682708 | Oct 1991 | SU |
WO 2005075186 | Aug 2005 | WO |
WO 2006047818 | May 2006 | WO |
2012122601 | Sep 2012 | WO |
Entry |
---|
Further Examination Report mailed Jan. 22, 2021 in related NZ Application 756591 (2 pages). |
First Examination Report mailed Feb. 12, 2021 in related NZ Application 772270 (3 pages). |
Pre-Appeal Examination Report and English translation thereof obtained Nov. 8, 2021 in related JP application 2019-100282 (6 pages). |
Office Action mailed Feb. 3, 2022 in related U.S. Appl. No. 16/912,857 (21 pages). |
Extended European Search Report mailed Feb. 2, 2023, in related EP Application No. 20756702.5 (8 pages). |
Notice of Allowance issued in related Japanese Application No. 2021-547237, three pages, dated Nov. 27, 2023. |
Japanese Office Action and English translation mailed Apr. 27, 2020 in JP Application 2019-007016. |
Final Office Action mailed Nov. 15, 2019 in related U.S. Appl. No. 15/599,889. |
JP Report on the Reexamination Prior to Trial and English translation thereof drafted Aug. 5, 2019 and retrieved from the JPO database Aug. 19, 2019 in related JP application 2017-159153. |
Definition of polymer. from Wikipedia, from May 13, 2019, see www.en.wikipedia.org /wiki /Polymer (17 pages). |
Non-Final Office Action mailed May 16, 2019 related U.S. Appl. No. 15/599,889 (34 pages). |
Further Examination Report mailed Apr. 29, 2019 in related NZ Patent Application No. 740448 (2 pages). |
Second Office Action issued in related Chinese Application No. 2016-109065994 dated Jan. 2, 2019, with English translation, (15 pages). |
Final Office Action issued in related Japanese Application No. 2017-159153 dated Feb. 15, 2019, with English translation, (8 pages). |
A First Office Action issued in related Japanese Application No. 2017-159153 dated Jul. 23, 2018, with English translation, (11 pages). |
A First Office Action issued Apr. 4, 2018, in a related Chinese Patent Application No. 201610906599.4 (10 pages), and an English translation thereof (8 pages). |
A First Examination Report issued Apr. 3, 2018, in a related New Zealand Patent Application No. 740448 (3 pages). |
Notice of Reasons for Rejection and English translation thereof mailed Mar. 22, 2022 in related JP application 2019-100282 (10 pages). |
European Search Report mailed Jul. 11, 2022 in related EP Application 21214525.4 (8 pages). |
Notice of Reasons for Rejection and English translation thereof mailed Aug. 1, 2022 in related JP Application 2021-146154 (10 pages). |
Final Rejection and English translation thereof mailed May 10, 2021 in related JP application 2019-100282 (7 pages). |
Notice of Reasons for Refusal and English translation in related Japanese Application No. 2023-220787, four pages, dated Apr. 30, 2024. |
Number | Date | Country | |
---|---|---|---|
20210001074 A1 | Jan 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12225417 | US | |
Child | 15425891 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15425891 | Feb 2017 | US |
Child | 17027809 | US |